Pneumonia caused by SARS-COV-2: diagnosis and treatment in outpatient settings

被引:0
|
作者
Melnyk, V. P. [1 ]
Panasiuk, O., V [1 ]
Sadomova-Andrianova, H., V [1 ]
Antoniuk, I., V [1 ]
Sliusarchuk, I. O. [1 ]
Solonynka, H. Ya [2 ]
机构
[1] PHEE Kyiv Med Univ, Dept Infect Dis Phthisiol & Pulmonol, Kiev, Ukraine
[2] PHEE Kyiv Med Univ, Dept Internal Med, Kiev, Ukraine
关键词
pneumonia; SARS-COV-2; familial foci of infection; diagnosis; outpatient care; CORONAVIRUS; CD147;
D O I
10.14739/2310-1210.2021.3.224926
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of the study was identifying the features of infection in the site, clinical course of the disease, amount and frequency of patient examinations, family doctor communications and treatment of patients with pneumonia caused by SARS-Cov2. Materials and methods. We examined 23 families of 2-6 members (a total of 78), among them 41 patients with SARS-COV-2 pneumonia. The amount of patient examination (PCR, plain X-ray and CT of the thoracic cavity, coagulogram, blood oxygen saturation) and treatment extent (antibacterial, anticoagulant and oxygen therapy) were considered. Results. The contagiousness of the disease in the families of patients was from 33 %to 100 %. The thoracic CT overuse: 73.3 % repeated, 33.0 %triple. Family doctors monitored the treatment only in 14.6 % of cases. The antibacterial therapy administration was 2 times more often than necessary; the treatment was changed by patients themselves or their acquaintances. A hospitalization was offered to patients with a decreased blood oxygen saturation of 92 % and below (29.3 %), and only 2 patients agreed to it. In a lack of treatment efficacy, the patients used respiratory fluoroquinolones (levofloxacin, moxifloxacin), meropenem, linezolid, amikacin, which are among the main drugs for the treatment of resistant tuberculosis. Extensive misuse of antibacterial drugs unnecessarily will result in an alarming increase in antibiotic-resistant infections after the COVID-19 pandemic. Conclusions. Pneumonia caused by SARS-COV-2 is a highly contagious disease in a family cluster (33-100 %). Routine administration of antibacterial drugs (especially levofloxacin, moxifloxanemine, meropenem, linezolid, amikacin) for patients with suspected SARS-COV-2 pneumonia by thoracic CT or PCR-confirmed without proven need is not only unnecessary, but even dangerous due to the potential increase in resistance to these drugs, which are the primary in the treatment of resistant tuberculosis. The anamnesis of the disease, oxyhemometry and coagulogram are of great importance when examining a patient with this pathology.
引用
收藏
页码:395 / 401
页数:7
相关论文
共 50 条
  • [1] Laboratory Diagnosis of SARS-CoV-2 Pneumonia
    Gitman, Melissa R.
    Shaban, Maryia, V
    Paniz-Mondolfi, Alberto E.
    Sordillo, Emilia M.
    [J]. DIAGNOSTICS, 2021, 11 (07)
  • [2] Tomographic behavior of pneumonia caused by SARS-CoV-2
    Concha-Rebollar, Luis A.
    Izquierdo-Echavarri, Eva A.
    Alva-Lopez, Luis F.
    Ayala-Ochoa, Francisco J.
    Hernandez-Melchor, Vito S.
    [J]. GACETA MEDICA DE MEXICO, 2020, 156 (05): : 396 - 404
  • [3] An incidental diagnosis in a patient with SARS-CoV-2 pneumonia
    Bava, Annita
    Arico, Concetta Nadia
    Caridi, Rocco
    Roda, Filippo
    Franzutti, Claudio
    Scappatura, Giuseppe
    Grillone, Nadine
    Rao, Massimo
    [J]. EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (0G)
  • [4] An incidental diagnosis in a patient with SARS-CoV-2 pneumonia
    Bava, Annita
    Arico, Concetta Nadia
    Caridi, Rocco
    Roda, Filippo
    Franzutti, Claudio
    Scappatura, Giuseppe
    Grillone, Nadine
    Rao, Massimo
    [J]. EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (SUPPL G)
  • [5] Antiviral treatment selection for SARS-CoV-2 pneumonia
    Bassetti, Matteo
    Corcione, Silvia
    Dettori, Silvia
    Lombardi, Andrea
    Lupia, Tommaso
    Vena, Antonio
    De Rosa, Francesco Giuseppe
    Gori, Andrea
    Giacobbe, Daniele Roberto
    [J]. EXPERT REVIEW OF RESPIRATORY MEDICINE, 2021, 15 (08) : 985 - 992
  • [6] Application of validated severity scores for pneumonia caused by SARS-CoV-2
    Ronda, Violeta Esteban
    Alcaraz, Sandra Ruiz
    Torregrosa, Paloma Ruiz
    Suau, Mario Gimenez
    Perez, Ester Nofuentes
    Ramirez, Jose Manuel Leon
    Andres, Mariano
    Moreno-Perez, Oscar
    Blanes, Alfredo Candela
    Carbonell, Joan Gil
    de Lucas, Esperanza Merino
    [J]. MEDICINA CLINICA, 2021, 157 (03): : 99 - 105
  • [7] Pneumothorax in a patient with pneumonia caused by SARS-CoV-2: A case report
    Novkovic, Ljiljana
    Cekerevac, Ivan
    [J]. VOJNOSANITETSKI PREGLED, 2021, 78 (03) : 361 - 365
  • [8] Corticosteroid Therapy in Severe Cases of Pneumonia Caused by SARS-CoV-2
    Alves, Joao
    Salgueiro, Andrea
    Baptista, Joao Pedro
    Martins, Paulo
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (12)
  • [9] Management of SARS-CoV-2 pneumonia
    Sagnelli, Caterina
    Celia, Benito
    Monari, Caterina
    Cirillo, Salvatore
    De Angelis, Giulia
    Bianco, Andrea
    Coppola, Nicola
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (03) : 1276 - 1287
  • [10] Compassionate Use of Tocilizumab for Treatment of SARS-CoV-2 Pneumonia
    Jordan, Stanley C.
    Zakowski, Phillip
    Tran, Hai P.
    Smith, Ethan A.
    Gaultier, Cyril
    Marks, Gregory
    Zabner, Rachel
    Lowenstein, Hayden
    Oft, Jillian
    Bluen, Benjamin
    Le, Catherine
    Shane, Rita
    Ammerman, Noriko
    Vo, Ashley
    Chen, Peter
    Kumar, Sanjeev
    Toyoda, Mieko
    Ge, Shili
    Huang, Edmund
    [J]. CLINICAL INFECTIOUS DISEASES, 2020, 71 (12) : 3168 - 3173